CRYO-CELL INTERNATIONAL, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-05-31 was $23.25K.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-11-30 was $0.00, a 100.00% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-08-31 was $23.10K, a 2205.49% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-11-30 was $75.40K.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $23.10K, a 69.76% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $76.40K.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for fiscal 2023 was -$2.86K, a 100.52% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $551.27K, a 51.15% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-05-31 | $23.25K 10-Q · filed 2026-07-15 | |
| 2025-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.10K 10-K · filed 2026-02-27 |
| 2025-08-31 | $23.10K 10-Q · filed 2025-10-15 | |
| 2024-11-30 | $75.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $76.40K 10-K · filed 2026-02-27 |
| 2024-08-31 | $1.00K 10-Q · filed 2025-10-15 | |
| 2023-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$2.86K 10-K · filed 2025-02-28 |
| 2023-08-31 | -$2.86K 10-Q · filed 2024-10-15 | |
| 2022-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $551.27K 10-K · filed 2024-02-28 |
| 2022-08-31 | $519.27K 10-Q · filed 2023-10-12 | -$2.83M derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | -$3.49M derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $32.00K 10-Q · filed 2023-04-21 | $968.89K derived: sum of 4 quarters · filed 2023-04-21 |
| 2021-11-30 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.13M 10-K · filed 2023-02-28 |
| 2021-08-31 | -$142.17K 10-Q · filed 2022-10-18 | |
| 2021-05-31 | $4.46M 10-Q · filed 2022-07-11 | |
| 2021-02-28 | $191.62K 10-Q · filed 2022-04-13 | |
| 2020-11-30 | $41.00K 10-K · filed 2022-02-22 | |
| 2014-11-30 | $79.14K 10-K · filed 2016-02-29 | |
| 2013-11-30 | $14.95K 10-K · filed 2015-03-02 | |
| 2012-11-30 | -$5.70K 10-K · filed 2014-02-28 | |
| 2011-11-30 | $80.94K 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |